The Prognostic Significance of the Metabolic Score for Insulin Resistance and Subclinical Myocardial Injury for Cardiovascular Mortality in the General Population
Open Access
- 2 February 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1141
Abstract
Background/Objectives: The Metabolic Score for Insulin Resistance (METS-IR), a non-insulin-based index of insulin resistance (IR), and subclinical myocardial injury (SCMI), identified by electrocardiogram (ECG), are each associated with cardiovascular disease (CVD). However, their joint impact on mortality remains unclear. We examined the association of the METS-IR with SCMI and evaluated the individual and combined associations of SCMI and IR with cardiovascular mortality. Methods: We analyzed adults without baseline CVD from the Third National Health and Nutrition Examination Survey (1988–1994) with mortality follow-up through 31 December 2019. The METS-IR was calculated from fasting glucose, triglycerides, high-density lipoprotein cholesterol, and body mass index and categorized as low (<75th percentile) or high (≥75th percentile). SCMI was defined as a cardiac infarction injury score ≥ 10 on ECG. Multivariable logistic regression assessed associations between the METS-IR and SCMI, and Cox regression estimated cardiovascular mortality risk across SCMI-IR combinations. Results: Among 6079 participants, 14.1% had SCMI. Higher METS-IR values were associated with greater SCMI odds (OR (95% CI): 1.58 (1.31–1.90)). Over a median of 18.8 years, 563 (9.1%) cardiovascular deaths occurred. Both SCMI and high IR were individually associated with increased cardiovascular mortality ((HR (95% CI): 1.41 (1.19–1.69) and 1.32 (1.09–1.59), respectively). Participants with both SCMI and high IR had the highest risk (HR 1.92; 95% CI 1.49–2.50) compared with those with neither condition. Conclusions: In adults without prior CVD, the METS-IR was positively associated with SCMI. The coexistence of SCMI and high IR identified a subgroup at nearly twofold higher risk of cardiovascular mortality, supporting the combined use of ECG-based injury markers and metabolic indices for cardiovascular risk stratification.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Nonlinear associations between METS-IR and all-cause as well as cardiovascular mortality in adults with osteoporosis and osteopenia: evidence from NHANES 2007–2023Scientific Reports, 2025
- Association between METS-IR index and obstructive sleep apnea: evidence from NHANESScientific Reports, 2025
- Association Between Family Income, Subclinical Myocardial Injury, and Cardiovascular Mortality in the General PopulationClinical Cardiology, 2024
- Linear positive association of metabolic score for insulin resistance with stroke risk among American adults: a cross-sectional analysis of National Health and Nutrition Examination Survey datasetsJournal of Stroke and Cerebrovascular Diseases, 2024
- When Is Science Significant? Understanding the p ValuePlastic and Reconstructive Surgery, 2020
- Subclinical Myocardial Injury Identified by Cardiac Infarction/Injury Score and the Risk of Mortality in Men and Women Free of Cardiovascular DiseaseThe American Journal of Cardiology, 2014
- Disordered Lipid Metabolism and the Pathogenesis of Insulin ResistancePhysiological Reviews, 2007
- Insulin resistance in non‐diabetic subjects is associated with increased incidence of myocardial infarction and deathDiabetic Medicine, 2002
- Cardiac Infarction Injury Score predicts cardiovascular mortality in apparently healthy men and women.Heart, 1994
- Cardiac infarction injury score: an electrocardiographic coding scheme for ischemic heart disease.Circulation, 1981